CVRx (CVRX) said late Monday that it expects to report roughly $12.3 million in Q1 revenue compared with $10.8 million during the year-ago period.
Analysts polled by FactSet, on average, expected $14.7 million.
The medical device company also said it finished the quarter ended March 31 with around $102.7 million in cash and cash equivalents, compared with $105.9 million at the end of December.
CVRx is scheduled to report its full Q1 financial results on May 8 after market close.
CVRx shares were sinking over 7% during after-hours session.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。